A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas
Clinical trial NCT03575351 · COMPLETED
Trial details
- NCT number
- NCT03575351
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-23
- Primary completion
- 2023-10-23
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.